SOPHiA GENETICS SOPH Stock
SOPHiA GENETICS Price Chart
SOPHiA GENETICS SOPH Financial and Trading Overview
| SOPHiA GENETICS stock price | 7.3 USD |
| Previous Close | 8.07 USD |
| Open | 8.1 USD |
| Bid | 5.89 USD x 200 |
| Ask | 10.25 USD x 200 |
| Day's Range | 7.9 - 8.34 USD |
| 52 Week Range | 3.75 - 8.98 USD |
| Volume | 1.18M USD |
| Avg. Volume | 525.3K USD |
| Market Cap | 698.05M USD |
| Beta (5Y Monthly) | 0.952 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.16 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.75 USD |
SOPH Valuation Measures
| Enterprise Value | 652.21M USD |
| Trailing P/E | N/A |
| Forward P/E | -16.4 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 8.101108 |
| Price/Book (mrq) | 8.401639 |
| Enterprise Value/Revenue | 7.569 |
| Enterprise Value/EBITDA | -9.091 |
Trading Information
SOPHiA GENETICS Stock Price History
| Beta (5Y Monthly) | 0.952 |
| 52-Week Change | 99.25% |
| S&P500 52-Week Change | 14.57% |
| 52 Week High | 8.98 USD |
| 52 Week Low | 3.75 USD |
| 50-Day Moving Average | 7.68 USD |
| 200-Day Moving Average | 5.7 USD |
SOPH Share Statistics
| Avg. Volume (3 month) | 525.3K USD |
| Avg. Daily Volume (10-Days) | 528.96K USD |
| Shares Outstanding | 85.13M |
| Float | 65.38M |
| Short Ratio | 1.73 |
| % Held by Insiders | 6.76% |
| % Held by Institutions | 62.31% |
| Shares Short | 1.07M |
| Short % of Float | 1.33% |
| Short % of Shares Outstanding | 1.26% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -93.86% |
| Operating Margin (ttm) | -86.027% |
| Gross Margin | 66.62% |
| EBITDA Margin | -83.26% |
Management Effectiveness
| Return on Assets (ttm) | -24.51% |
| Return on Equity (ttm) | -101.21% |
Income Statement
| Revenue (ttm) | 86.17M USD |
| Revenue Per Share (ttm) | 1.24 USD |
| Quarterly Revenue Growth (yoy) | 27.20% |
| Gross Profit (ttm) | 57.41M USD |
| EBITDA | -71746000 USD |
| Net Income Avi to Common (ttm) | -80878000 USD |
| Diluted EPS (ttm) | -1.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 107.67M USD |
| Total Cash Per Share (mrq) | 1.27 USD |
| Total Debt (mrq) | 61.83M USD |
| Total Debt/Equity (mrq) | 74.39 USD |
| Current Ratio (mrq) | 2.688 |
| Book Value Per Share (mrq) | 0.976 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -39741000 USD |
| Levered Free Cash Flow (ttm) | -25659124 USD |
Profile of SOPHiA GENETICS
| Country | United States |
| State | N/A |
| City | Rolle |
| Address | La PiEce 12 |
| ZIP | 1180 |
| Phone | 41 21 694 10 60 |
| Website | https://www.sophiagenetics.com |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 415 |
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom and a collaboration with AstraZeneca to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies. The company was incorporated in 2011 and is based in Rolle, Switzerland.
Q&A For SOPHiA GENETICS Stock
What is a current SOPH stock price?
SOPHiA GENETICS SOPH stock price today per share is 7.3 USD.
How to purchase SOPHiA GENETICS stock?
You can buy SOPH shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SOPHiA GENETICS?
The stock symbol or ticker of SOPHiA GENETICS is SOPH.
Which industry does the SOPHiA GENETICS company belong to?
The SOPHiA GENETICS industry is Health Information Services.
How many shares does SOPHiA GENETICS have in circulation?
The max supply of SOPHiA GENETICS shares is 85.13M.
What is SOPHiA GENETICS Price to Earnings Ratio (PE Ratio)?
SOPHiA GENETICS PE Ratio is now.
What was SOPHiA GENETICS earnings per share over the trailing 12 months (TTM)?
SOPHiA GENETICS EPS is -1.16 USD over the trailing 12 months.
Which sector does the SOPHiA GENETICS company belong to?
The SOPHiA GENETICS sector is Healthcare.
SOPHiA GENETICS SOPH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27193.34 USD — |
-1.25
|
7.83B USD — | 27066.76 USD — | 27491.9 USD — | — - | 7.83B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
13390.94 USD — |
-1.26
|
— — | 13329.2 USD — | 13540.94 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1285.8 USD — |
-0.77
|
— — | 1265.56 USD — | 1286.72 USD — | — - | — — |
- {{ link.label }} {{link}}
